Integrated Diagnostics Holdings plc Share Price

Equities

IDHC

JE00BLKGSR75

Healthcare Facilities & Services

Market Closed - London S.E. 09:05:08 10/05/2024 pm IST 5-day change 1st Jan Change
0.328 USD +3.14% Intraday chart for Integrated Diagnostics Holdings plc +3.47% -7.61%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 5.42B 115M 9.58B Sales 2025 * 6.55B 139M 11.58B Capitalization 9.33B 197M 16.49B
Net income 2024 * 822M 17.4M 1.45B Net income 2025 * 982M 20.79M 1.74B EV / Sales 2024 * 1.64 x
Net cash position 2024 * 438M 9.27M 774M Net cash position 2025 * 982M 20.79M 1.74B EV / Sales 2025 * 1.27 x
P/E ratio 2024 *
11.9 x
P/E ratio 2025 *
8.34 x
Employees 6,692
Yield 2024 *
6.71%
Yield 2025 *
9.59%
Free-Float 51.88%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Integrated Diagnostics Holdings plc

1 day+3.14%
1 week+3.47%
Current month+6.84%
1 month-10.99%
3 months+5.47%
6 months+7.01%
Current year-7.61%
More quotes
1 week
0.32
Extreme 0.317
0.33
1 month
0.29
Extreme 0.293
0.37
Current year
0.29
Extreme 0.29
0.43
1 year
0.29
Extreme 0.29
0.63
3 years
0.29
Extreme 0.29
1.45
5 years
0.29
Extreme 0.29
1.45
10 years
0.29
Extreme 0.29
1.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 01/12/01
Director of Finance/CFO - 18/01
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman 66 12/15/12
Director/Board Member 58 12/15/12
Director/Board Member 59 23/14/23
More insiders
Date Price Change Volume
10/24/10 0.328 +3.14% 498
09/24/09 0.318 -0.47% 12,431,560
08/24/08 0.3195 +0.79% 6,591,922
07/24/07 0.317 0.00% 2,430,609

Delayed Quote London S.E., May 10, 2024 at 09:05 pm IST

More quotes
Integrated Diagnostics Holdings PLC is a consumer healthcare company. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology and others. The Company’s brands include Al Borg Scan, Al Mokhtabar, Ultralab, Biolab, Echo-Lab and others. It operates in approximately 552 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), electromyography (EMG), electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.55 EGP
Average target price
32.81 EGP
Spread / Average Target
+111.04%
Consensus

Quarterly revenue - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW